Tests for Immune Competency
Begin with screening tests for all four arms of immunity: complete blood count with differential, serum immunoglobulin levels (IgG, IgA, IgM), specific antibody titers, and CH50 complement assay, then advance to specialized testing based on clinical presentation and initial results. 1
Screening Tests by Immune Component
Humoral (Antibody) Immunity
- Serum immunoglobulin levels: Measure IgG, IgA, and IgM
- Specific antibody titers: Check responses to prior vaccinations (tetanus, diphtheria, pneumococcal)
- Antibody response to booster immunization: If baseline titers are low, administer booster and remeasure in 4-6 weeks to assess functional antibody production
- Flow cytometry: Enumerate total B cells 1
Critical interpretation point: Immunoglobulin levels alone are insufficient—you must document functional antibody production to both protein antigens (tetanus, diphtheria) and polysaccharide antigens (pneumococcal) to diagnose antibody deficiency. Normal immunoglobulin levels with poor vaccine responses indicate specific antibody deficiency 1.
Cellular (T-cell) Immunity
- Flow cytometry: Enumerate CD4+ and CD8+ T cells and NK cells
- TREC newborn screening: For infants (detects severe combined immunodeficiency)
- Cutaneous delayed hypersensitivity: Skin testing (though less commonly used now)
- Spontaneous NK cytotoxicity 1
Phagocytic Cell Function
- Complete blood count with differential: Absolute neutrophil count
- Peripheral blood smear: Neutrophil morphology and staining
- DHR (dihydrorhodamine) reduction test or nitroblue tetrazolium: Screens for chronic granulomatous disease
- Flow cytometry for adhesion molecules: Evaluates leukocyte adhesion deficiency 1
Complement System
- CH50 assay: Screens classical pathway (total hemolytic complement activity)
- AH50 assay: Screens alternative pathway
- Lectin pathway function 1
Advanced/Specialized Testing
Progress to these when screening tests are abnormal or clinical suspicion remains high despite normal screening:
Advanced Humoral Testing
- Flow cytometry for B-cell subsets: Naive and switched memory B cells (particularly useful in CVID classification)
- In vitro immunoglobulin production: Response to mitogens or other stimuli
- Antibody response to φX174 bacteriophage: Research test for antibody production 1
Advanced Cellular Testing
- Flow cytometry for T-cell subsets: Naive, memory, and activated cells
- In vitro proliferative response: To mitogens (PHA, ConA) and antigens
- T-cell cytotoxicity assays
- Surface marker expression and cytokine production: In response to stimuli
- Cytoplasmic protein phosphorylation: Evaluates signaling pathways 1
Advanced Phagocyte Testing
- Chemotaxis and phagocytosis assays
- Enzyme assays: Myeloperoxidase, G6PDH
- Bacterial or fungal killing assays
- Bone marrow biopsy: When indicated 1
Advanced Complement Testing
- Individual complement component levels: C3, C4, and specific components based on pathway defects 1
Genetic Testing
When immunodeficiency is confirmed or strongly suspected:
- Microarray for copy number variation: First-line genetic test
- Targeted gene sequencing: When specific disorder suspected
- Whole-exome/genome sequencing: For undefined cases 1
Clinical Context Matters
The pattern of infections guides testing priorities:
- Recurrent sinopulmonary infections with encapsulated bacteria → Focus on humoral immunity
- Opportunistic infections (Pneumocystis, fungal) → Focus on cellular immunity
- Deep-seated abscesses with catalase-positive organisms → Test for chronic granulomatous disease (DHR test)
- Recurrent Neisseria infections → Evaluate complement system 1
Common Pitfalls
- Don't rely on immunoglobulin levels alone: Patients can have normal or even elevated immunoglobulins but still have functional antibody deficiency
- Interpret results age-appropriately: Immunoglobulin levels vary significantly by age; use age-specific reference ranges
- Don't diagnose CVID before age 4 years: Transient hypogammaglobulinemia of infancy resolves with age 1
- Consider secondary causes: Medications, protein loss, malignancy, and bone marrow failure can cause hypogammaglobulinemia 1
The algorithmic approach starts broad with screening tests across all immune components, then narrows based on clinical presentation and initial abnormalities, ultimately progressing to genetic confirmation when a specific primary immunodeficiency is identified 2, 3.